Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 1
1955 1
1957 1
1958 1
1959 1
1961 1
1962 1
1964 1
1977 5
1978 27
1979 31
1980 70
1981 140
1982 337
1983 437
1984 643
1985 929
1986 1174
1987 1415
1988 1492
1989 1689
1990 1655
1991 1679
1992 1719
1993 1658
1994 1516
1995 1518
1996 1427
1997 1243
1998 1234
1999 1181
2000 1190
2001 1057
2002 1069
2003 1053
2004 902
2005 956
2006 873
2007 900
2008 899
2009 860
2010 833
2011 842
2012 873
2013 759
2014 786
2015 670
2016 632
2017 544
2018 499
2019 435
2020 417
2021 392
2022 598
2023 493
2024 361
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40,615 results

Results by year

Filters applied: . Clear all
Page 1
Revisiting IL-2: Biology and therapeutic prospects.
Abbas AK, Trotta E, R Simeonov D, Marson A, Bluestone JA. Abbas AK, et al. Sci Immunol. 2018 Jul 6;3(25):eaat1482. doi: 10.1126/sciimmunol.aat1482. Sci Immunol. 2018. PMID: 29980618 Review.
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.
Graßhoff H, Comdühr S, Monne LR, Müller A, Lamprecht P, Riemekasten G, Humrich JY. Graßhoff H, et al. Front Immunol. 2021 Apr 1;12:648408. doi: 10.3389/fimmu.2021.648408. eCollection 2021. Front Immunol. 2021. PMID: 33868284 Free PMC article. Review.
Interleukin-2 and leukemia.
Goodman M, Cabral L, Cassileth P. Goodman M, et al. Leukemia. 1998 Nov;12(11):1671-5. doi: 10.1038/sj.leu.2401199. Leukemia. 1998. PMID: 9823939 Review.
Interleukin-2 self-association.
Fleischmann JD, Wentworth D, Valencic F, Imbembo AL, Koehler KA. Fleischmann JD, et al. Biochem Biophys Res Commun. 1988 Apr 29;152(2):879-85. doi: 10.1016/s0006-291x(88)80121-9. Biochem Biophys Res Commun. 1988. PMID: 3259135
Interleukin-2.
Smith KA. Smith KA. Curr Opin Immunol. 1992 Jun;4(3):271-6. doi: 10.1016/0952-7915(92)90076-q. Curr Opin Immunol. 1992. PMID: 1418705 Review.
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.
Wang H, Borlongan M, Hemminki A, Basnet S, Sah N, Kaufman HL, Rabkin SD, Saha D. Wang H, et al. Hum Gene Ther. 2023 Sep;34(17-18):878-895. doi: 10.1089/hum.2023.099. Hum Gene Ther. 2023. PMID: 37578106 Free PMC article. Review.
Therapeutic potential of interleukin-2 in autoimmune diseases.
Yuan Y, Kolios AGA, Liu Y, Zhang B, Li H, Tsokos GC, Zhang X. Yuan Y, et al. Trends Mol Med. 2022 Jul;28(7):596-612. doi: 10.1016/j.molmed.2022.04.010. Epub 2022 May 24. Trends Mol Med. 2022. PMID: 35624009 Review.
40,615 results
You have reached the last available page of results. Please see the User Guide for more information.